Page last updated: 2024-10-25

desipramine and Infant, Newborn, Diseases

desipramine has been researched along with Infant, Newborn, Diseases in 2 studies

Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.

Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Webster, PA1
Rane, A1
Lunde, PK1
Jalling, B1
Yaffe, SJ1
Sjöqvist, F1

Other Studies

2 other studies available for desipramine and Infant, Newborn, Diseases

ArticleYear
Withdrawal symptoms in neonates associated with maternal antidepressant therapy.
    Lancet (London, England), 1973, Aug-11, Volume: 2, Issue:7824

    Topics: Adult; Depression; Desipramine; Female; Fetus; Humans; Infant, Newborn; Infant, Newborn, Diseases; M

1973
Plasma protein binding of diphenylhydantoin in normal and hyperbilirubinemic infants.
    The Journal of pediatrics, 1971, Volume: 78, Issue:5

    Topics: Bilirubin; Binding Sites; Blood Proteins; Carbon Isotopes; Desipramine; Female; Filtration; Humans;

1971